Literature DB >> 8549287

Fluoroquinolone toxicities. An update.

P S Lietman1.   

Abstract

The main types of adverse effects associated with quinolones are uncommon and reversible and vary in frequency among different agents. Phototoxicity appears more frequent with lomefloxacin than with some other quinolones. Three mechanisms have been proposed to explain the neurotoxic effects, including rare proconvulsant activity, associated with quinolone therapy. Arthropathy remains a dilemma for paediatricians deciding whether to use quinolones in growing children. Importantly, the experience with temafloxacin, which has now been withdrawn from the market, emphasises the need for thorough postmarketing surveillance. Nonetheless, it should be remembered that the fluoroquinolones as a group are effective and very well tolerated antimicrobial drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549287     DOI: 10.2165/00003495-199500492-00026

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  20 in total

1.  The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from rat dorsal root ganglion neurones.

Authors:  R F Halliwell; P G Davey; J J Lambert
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

Review 2.  Antagonism of GABAA receptors by 4-quinolones.

Authors:  R F Halliwell; P G Davey; J J Lambert
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

3.  Temafloxacin-induced hemolytic anemia and renal failure.

Authors:  R L Deamer; J G Prichard; N Koenker; R E James; D Heming
Journal:  Clin Pharm       Date:  1993-05

Review 4.  Safety and tolerability of fluoroquinolones.

Authors:  S R Norrby; P S Lietman
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.

Authors:  A De Sarro; M Zappalá; A Chimirri; S Grasso; G B De Sarro
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

6.  Ciprofloxacin and sparfloxacin penetration into human brain tissue and their activity as antagonists of GABAA receptor of rat vagus nerve.

Authors:  P G Davey; M Charter; S Kelly; T R Varma; I Jacobson; A Freeman; E Precious; J Lambert
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation.

Authors:  M Matsumoto; K Kojima; H Nagano; S Matsubara; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

8.  Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.

Authors:  K Marutani; M Matsumoto; Y Otabe; M Nagamuta; K Tanaka; A Miyoshi; T Hasegawa; H Nagano; S Matsubara; R Kamide
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

9.  Magnetic resonance imaging in diagnosis of potential arthropathogenicity in children receiving quinolones. No evidence of quinolone-induced arthropathy.

Authors:  A Danisovicová; T Krcméryová; S Belan; H Kayserová; I Hruskovic; M Brezina; E Kaiserová; T Rovensky; S Dluholucky; V Krcméry
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 10.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

View more
  15 in total

Review 1.  Quinolones: which generation for which microbe?

Authors:  M K Lee; M S Kanatani
Journal:  West J Med       Date:  1999-06

2.  Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.

Authors:  L Naldi; A Conforti; M Venegoni; M G Troncon; A Caputi; E Ghiotto; A Cocci; U Moretti; G Velo; R Leone
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

3.  Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study.

Authors:  Giovanni Corrao; Antonella Zambon; Lorenza Bertù; Anna Mauri; Valentina Paleari; Camillo Rossi; Mauro Venegoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Early postoperative fluoroquinolone use is associated with an increased revision rate after arthroscopic rotator cuff repair.

Authors:  Jourdan M Cancienne; Stephen F Brockmeier; Scott A Rodeo; Chris Young; Brian C Werner
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-13       Impact factor: 4.342

Review 5.  Fluoroquinolone-induced renal failure.

Authors:  B M Lomaestro
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

6.  The new fluoroquinolones: A critical review.

Authors:  G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal:  Can J Infect Dis       Date:  1999-05

Review 7.  Comparative tolerability of the newer fluoroquinolone antibacterials.

Authors:  P Ball; L Mandell; Y Niki; G Tillotson
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

Review 8.  Quinolones in the aged.

Authors:  L E Nicolle
Journal:  Drugs       Date:  1999       Impact factor: 9.546

9.  Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.

Authors:  M Solèr; H Lode; R Baldwin; J H A Levine; A J M Schreurs; J A van Noord; F P V Maesen; M Zehrer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

10.  Safety of fluoroquinolones: An update.

Authors:  L Mandell; G Tillotson
Journal:  Can J Infect Dis       Date:  2002-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.